At a glance
ClinicalIndex Comparison RecordN/ACompleted· 19 enrolled
Drug / intervention
oral glucose tolerance test +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Prandial Liver Glucose Metabolism in Polycystic Ovarian Syndrome (PCOS) and Understanding Standard of Care Medications
In Brief
An observational study evaluating oral glucose tolerance test and MRI of liver for Polycystic Ovarian Syndrome and 2 related conditions. Completed, enrolled 19 participants across 1 site.
Detailed Summary
The Investigators will measure if hepatic metabolism is upregulated in obese girls with PCOS and hepatic steatosis (HS), compared to PCOS without HS and obese controls without HS.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovarian Syndrome, Obesity, Hepatic Steatosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2017
Enrollment StartApr 2017
Primary CompletionAug 2018
Study CompletionSep 2018
TodayJul 2026
First PostedFeb 2, 2017
Enrollment StartApr 14, 2017
Primary CompletionAug 29, 2018
Study CompletionSep 29, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.4 years ago
Interventions
oral glucose tolerance testother
6 hours OGTT
MRI of liverother
MRI of the liver and use of DIXON method